Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma. | Front Genet | 2022 | 36186418 | PubTator, text mining | PubMed |
Integrated TCR repertoire analysis and single-cell transcriptomic profiling of tumor-infiltrating T cells in renal cell carcinoma identifies shared and tumor-restricted expanded clones with unique phenotypes. | Front Oncol | 2022 | 36185254 | PubTator, text mining | PubMed |
| BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies. | J Hematol Oncol | 2022 | 36183125 | PubTator, text mining | PubMed |
| The human splenic microcirculation is entirely open as shown by 3D models in virtual reality. | Sci Rep | 2022 | 36182999 | PubTator, text mining | PubMed |
| Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression? | CNS Drugs | 2022 | 36178589 | PubTator, text mining | PubMed |
| Expression of ICOS in the salivary glands of patients with primary Sjogren's syndrome and its molecular mechanism. | Mol Med Rep | 2022 | 36177915 | PubTator, text mining | PubMed |
| Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical. | Drug Des Devel Ther | 2022 | 36164415 | PubTator, text mining | PubMed |
| PD-1 combined with TRBC1 and pan-T cell antibodies for robustly monitoring angioimmunoblastic T-cell lymphoma. | Front Med (Lausanne) | 2022 | 36160159 | PubTator, text mining | PubMed |
| Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape. | Leukemia | 2022 | 36153436 | PubTator, text mining | PubMed |
| Antiretroviral Drug Discovery Targeting the HIV-1 Nef Virulence Factor. | Viruses | 2022 | 36146831 | PubTator, text mining | PubMed |
| Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors. | Viruses | 2022 | 36146786 | PubTator, text mining | PubMed |
| Adult-Onset Familial Hemophagocytic Lymphohistiocytosis Presenting with Annular Erythema following COVID-19 Vaccination. | Vaccines (Basel) | 2022 | 36146514 | PubTator, text mining | PubMed |
| Co-Stimulatory Receptor Signaling in CAR-T Cells. | Biomolecules | 2022 | 36139142 | PubTator, text mining | PubMed |
| Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect. | Exp Hematol Oncol | 2022 | 36138486 | PubTator, text mining | PubMed |
| The HIV-1 protein Nef activates the Tec family kinase Btk by stabilizing an intermolecular SH3-SH2 domain interaction. | Sci Signal | 2022 | 36126115 | PubTator, text mining | PubMed |
| Management of relapsed/refractory Chronic Lymphocytic Leukemia. | Am J Hematol | 2022 | 36125037 | PubTator, text mining | PubMed |
| Risk of HBV reactivation in relapsed or refractory diffuse large B-cell lymphoma patients receiving Bruton tyrosine kinase inhibitors therapy. | Front Immunol | 2022 | 36119029 | PubTator, text mining | PubMed |
| Tuberculosis infection related hemophagocytic lymphohistiocytosis diagnosed in patient with GZMB mutation: A case report and literature review. | Medicine (Baltimore) | 2022 | 36107603 | PubTator, text mining | PubMed |
| Distinct gene expression patterns for CD14++ and CD16++ monocytes in preeclampsia. | Sci Rep | 2022 | 36104441 | PubTator, text mining | PubMed |
| Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia. | J Clin Invest | 2022 | 36099049 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=27